You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
药明康德(603259.SH)拟向特定对象增发不超6820.54万股H股
格隆汇 03-24 22:12

格隆汇3月24日丨药明康德(603259.SH)公布,2020年3月24日,经公司第一届董事会第三十九次会议暨2019年年度董事会会议,审议通过《关于公司增发H股股票方案的议案》。

为扩大H股投资者基础、扩大全球产能及优化公司资本结构,公司拟提请公司2019年年度股东大会、2020年第一次A股类别股东会议及2020年第一次H股类别股东会议批准特别授权以新增发行H股。

公司将向特定对象增发不超过6820.54万股H股,增发H股的募集资金在扣除发行相关费用后的净额将用于以下用途:

1.约35%将用于并购项目,包括但不仅限于通过并购扩大公司及其子公司在美国、欧洲和亚太地区的业务;

2.约20%将用于拓展公司及其子公司的海外业务;

3.约15%将用于常熟药明康德新药生产和研发一体化项目(一期);

4.约10%将用于偿还银行贷款及其他借款;以及5.剩余金额将用于补充一般运营资金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account